The treatment Alzheimer's and schizophrenia

Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it. Donate online now

Synosia Therapeutics announced today that it has started a Phase I clinical trial of SYN-120, its new generation 5-HT6 antagonist under development for the treatment of cognitive impairment associated with Alzheimer's and schizophrenia. The study will assess the safety and tolerability of single ascending doses of SYN-120 in healthy volunteers.

Dr Ian Massey, Chief Executive Officer and President of Synosia Therapeutics said: "It's a tribute to our team to be launching this study within months of acquiring SYN-120 through our partnership with Roche. It demonstrates our ability to efficiently and rapidly initiate and conduct clinical trials and to shorten the product development cycle".

Alzheimer's is an incurable disease, predominantly occurring in the elderly. Driven by the ageing population, prevalence of the disease is expected to double by 2025. Industry analysts Lead Discovery state that revenues of approved Alzheimer's disease drugs across major markets (US, Japan, France, Germany, Italy, Spain and the UK) totalled over $3bn in 2006, with revenues expected to exceed $5bn by 2012.

Schizophrenia is a severe form of mental illness, affecting about 24 million people worldwide. Cognitive impairment has long been recognised as a core feature of schizophrenia. It is present in the majority of patients, independent of symptoms such as delusions and hallucinations, and a major cause of poor social and vocational outcome. There are currently no medications approved for the treatment of cognitive impairment in schizophrenia ... http://www.medicalnewstoday.com

New high bioavailability DHA reaches North America

A concentrated DHA ingredient that claims to closely resemble DHA found in human breast milk has been launched on the North American market, following a distribution agreement between Spanish firm Brudy and New Jersey-based Xsto Solutions. ...http://www.nutraingredients.com

Беларусь ТВ

Weather Foreca

Гiсторыя, якая павiнна жыць

Канцэпцыя Нацыянальнага гiстарычнага музея распрацаваная, надрукаваная i цяпер iдзе яе грамадскае абмеркаванне. Пра гэта паведамiў Сяргей Вечар, дырэк ДАЛЕЙ Posted YVN